{"id":233127,"date":"2021-01-15T13:06:14","date_gmt":"2021-01-15T18:06:14","guid":{"rendered":"https:\/\/oncubanews.com\/en\/?p=233127"},"modified":"2021-01-15T13:06:14","modified_gmt":"2021-01-15T18:06:14","slug":"a-new-diagnostic-kit-and-more-vaccine-projects-contributions-of-cuban-science-against-covid-19","status":"publish","type":"post","link":"https:\/\/oncubanews.com\/en\/cuba\/a-new-diagnostic-kit-and-more-vaccine-projects-contributions-of-cuban-science-against-covid-19\/","title":{"rendered":"A new diagnostic kit and more vaccine projects, contributions of Cuban science against COVID-19"},"content":{"rendered":"

A diagnostic kit for the detection of SARS-CoV-2 and new vaccine candidates more resistant to possible mutations of the <\/span>coronavirus<\/span><\/a>, are among the most recent contributions and results of Cuban science in the face of the pandemic, the official media reported.<\/span><\/p>\n

In addition, a third prototype of a Cuban lung ventilator was also presented, \u201can initiative that seeks to avoid the collapse of intensive care services in the absence of these equipment,\u201d <\/span>according to<\/span><\/a> Prensa Latina (PL)<\/em> news agency.<\/span><\/p>\n

The new diagnostic kit, which is used for the magnetic extraction of RNA from the virus with nanotechnology, was presented at the meeting that Cuban President Miguel D\u00edaz-Canel systematically holds with scientists and experts from the island working on projects and research related to COVID -19.<\/span><\/p>\n

\u201cIt is the laboratory reagent that allows the extraction of genetic material, which is an essential step in the process of determination of PCR tests,\u201d explained at the meeting Dr. Angelina D\u00edaz, director of the Center for Advanced Studies, <\/span>quoted<\/span><\/a> by <\/span>Granma<\/span><\/i> newspaper.<\/span><\/p>\n

The specialist stated that the diagnostic kit was validated by the Pedro Kour\u00ed Institute of Tropical Medicine, has a 100% concordance with imported kits, does not require a cold chain and complies with the standards of the Cuban regulatory authority.<\/span><\/p>\n

Dr. D\u00edaz said that the aim is to produce kits for 20,000 daily samples, \u201cfrom a production chain that involves several institutions, including a self-employed worker,\u201d <\/span>Granma<\/span><\/i> noted, recalling that \u201cso far, Cuba has managed to produce the swab for sampling, the means of transportation for their collection and transfer.\u201d<\/span><\/p>\n

For his part, Dr. Rolando P\u00e9rez, director of science and innovation of the BioCubaFarma business group, said that the idea is to assemble the complete system for the final diagnosis and that the created capacities would not only be for COVID-19, but for any disease of viral, bacterial and chronic non-communicable origin, including cancer.<\/span><\/p>\n

\u201cThe project involves reaching the team that processes the PCR test, not just the person who does it. We are going to produce everything that is required for molecular diagnosis and we think that by 2022 we will have all that technology,\u201d said P\u00e9rez at the meeting with D\u00edaz-Canel, where, in addition, the results of studies on COVID-19 as a cause of death in 50 autopsies and on the aftereffects it leaves in several organs were presented. These studies contribute to a new treatment protocol for the disease that will be presented shortly.<\/span><\/p>\n

Secuelas renales de la COVID-19 en la mira de la ciencia cubana<\/a><\/p><\/blockquote>\n